Investing.com - Illumina reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Illumina announced earnings per share of $1.07 on revenue of $1.22B. Analysts polled by Investing.com EPS of $0.8972 on revenue of $1.22B.
Illumina 's are up 38.94% and is trading at $298.48 , still down 44.54% from its 52 week high of $526.00 set on Monday, August 16, 2021.
Illumina shares gained 2.32% to trade at $298.48 in after-hours trade the report.
Illumina follows other major Healthcare sector earnings this month
Illumina's report follows an earnings beat by J&J on Tuesday, April 19, 2022, who reported EPS of $2.67 on revenue of $23.43B, EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on Thursday, April 14, 2022 with first quarter EPS of $5.49 on revenue of $80.15B, for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar